Savvy Trades and Investments

[wadegarret]

HZNP($76.50) looks cheap IMO

JP Morgan upgraded to $110 target, and the average target is now around $100. I see the stock as a good hold till at least $100, but could very well be a good long term hold. It all depends on their latest drug Tepezza, which is supposed to bring in $2B+/year starting 2021. Also their gout drug Krystexxa is growing revenues strong yoy & doing around $500M/year now. I believe a 20+ PE going forward is warranted on this one, and that would take the stock to well over $100 if the company comes through on Tepezza. With the recent offering at $71, I believe that sets a floor on the stock, so little downside risk IMO.